tumor microenvironment

Chemotherapy drugs can kill cancer cells by halting DNA replication, but a glucose-depleted environment can help cancer cells overcome this effect and resist death. 

New 3D blueprints that highlight tumor complexity reveal several new discoveries, some of which challenge existing theories of cancer progression.

Researchers explore the immune system to further understand cancer and illuminate therapy development.

Immune cells form different communities throughout a tumor, potentially disrupting how cancers respond to treatments.

Superior quality cytokines are crucial for reliable research results and the safe production of cancer cell therapies.

Cancer-supporting cells control their neighbors’ behavior using an often-overlooked protein delivery system. 

In this webinar, Matthias Brendel will discuss a new PET approach called scRadiotracing, which involves immunomagnetic cell sorting after in vivo radiotracer injection combined with 3D histology.

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies.

An essential staining technique with a long history, immunohistochemistry (IHC) is being upgraded for modern research and clinical applications.

Researchers connect a tumor’s leading edge transcriptional profile to poor survival outcomes across cancer types. 

Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.

Researchers built a 3D glioblastoma model to study therapeutic resistance and improve drug screening systems.

Scientists present the latest research on immune cell responses to cancer, the role of epigenetics in cancer, and molecular imaging of the tumor microenvironment.

Learn about the tumor microenvironment (TME), a key influencer of cancer growth, spread, and treatment success.

Biofilms are home to millions of microbes, but disrupting their interactions could produce more effective antibiotics.

Free-swimming bacteria settle on a surface to cooperate and form a protective biofilm.

Colonizing tumors with engineered bacteria may allow researchers to target sites currently inaccessible to radionuclide therapy.

The University of Chicago cell biologist is studying how the nutrients available to cancers influence their growth. 

Research into how pancreatic tumors adapt to stress could lead to a new treatment approach.